N-Myc is a downstream target of RET signaling and is required for transcriptional regulation of p18Ink4c by the transforming mutant RETC634R

Molecular Oncology

Volumn 5, Issue 1, 2011, Pages 24-35

  Kulkarni, Mandar V ^a   Franklin, David S ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Cell cycle; Initiator element; N Myc; P18Ink4c; RET; Transcription

Indexed keywords

CYCLIN D1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P18; PROTEIN P27;

ARTICLE; BINDING SITE; CARCINOGENESIS; CELL TYPE; DOWNSTREAM PROCESSING; ENDOCRINE TUMOR; FETUS DEATH; HUMAN; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; MUTANT; NEUROSECRETORY CELL; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR DOWN REGULATION; STEM CELL; TRANSCRIPTION REGULATION; UPREGULATION;

MUS;

EID: 78951477845     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2010.10.004     Document Type: Article

References (36)

1. Acton A., Hoppener J.W.M., Lips C.J.M. Involvement of the cell cycle regulator P18/INK4C/CDKN2C in human medullary thyroid carcinoma development. J. Intern. Med. 2004, 255:696-730.
2. Aubry S., Charron J. N-Myc shares cellular functions wiht c-Myc. DNA Cell Biol. 2000, 19:353-364.
3. Bianchi A.B., et al. Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 1993, 8:1127-1133.
4. Blackwell T.K., et al. Binding of myc proteins to canonical and noncanonical DNA sequences. Mol. Cell Biol. 1993, 13:5216-5224.
5. Blais A., et al. Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1. J. Biol. Chem. 2002, 277:31679-31693.
6. Charron J., et al. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 1992, 6:2248-2257.
7. Davis A.C., et al. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 1993, 7:671-682.
8. Downs K.M., et al. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 1989, 3:860-869.
9. Eberhardy S.R., et al. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation. J. Biol. Chem. 2000, 275:33798-33805.
10. Franklin D., et al. CDK inhibitors p18INK4c and p27KIP1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 1998, 12:2899-2911.
11. Franklin D., et al. Functional collaboration between different cyclin-dependent kinase inhibitors Suppresses tumor growth with distinct tissue specificity. Mol. Cell. Biol. 2000, 20:6147-6158.
12. Franklin D., Xiong Y. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol. Biol. Cell 1996, 7:1587-1599.
13. Hunter T., Pines J. Cyclins and cancer. Cell 1991, 66:1071-1074.
14. Jenkins C., Xiong Y. Immunoprecipitation and immunoblotting in cell cycle studies. Cell Cycle: Material and Methods 1995, 250-263. Springer-Verlag, New York. M. Pagano (Ed.).
15. Joshi P.P., et al. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis. Oncogene 2007, 26:554-570.
16. Juan G., Darzynkiewicz Z. Bivariate analysis of DNA content and expression of cyclin proteins. Curr Protoc. Cytom 2001, Chapter 7, Unit 7.9.
17. Knoepfler P.S., et al. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 2002, 16:2699-2712.
18. Kodama Y., et al. The RET proto-oncogene: a molecular therapeutic target in thyroid cancer. Cancer Sci. 2005, 96:143-148.
19. Lovec H., et al. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 1994, 13:3487-3495.
20. Loves H., et al. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 1994, 9:323-326.
21. Misawa A., et al. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells. Cancer Res. 2000, 60:64-69.
22. Pei X.H., et al. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell 2009, 15:389-401.
23. Peukert K., et al. An alternative pathway for gene regulation by Myc. EMBO J. 1997, 16:5672-5686.
24. Phelps D.E., et al. Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol. Cell. Biol. 1998, 18:2334-2343.
25. Phelps D.E., Xiong Y. Regulation of CDK4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27KIP1. Cell Growth Differ. 1998, 9:595-610.
26. Sawai S., et al. Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. New Biol. 1991, 3:861-869.
27. Schneider A., et al. Association of Myc with the zinc-finger protein Miz-1 defines a novel pathway for gene regulation by Myc. Curr. Top. Microbiol. Immunol. 1997, 224:137-146.
28. Sherr C. Mammalian G1 cyclins. Cell 1993, 73:1059-1065.
29. Sherr C., Roberts J. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.
30. Sherr C.J. G1 phase progression: cycling on cue. Cell 1994, 79:551-555.
31. Sherr C.J. Cancer cell cycle. Science 1996, 274:1672-1677.
32. Soucek L., et al. Modelling Myc inhibition as a cancer therapy. Nature 2008, 455:679-683.
33. van Veelen W., et al. P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development. Int. J. Cancer 2009, 124:339-345.
34. Vitagliano D., et al. Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. Cancer Res. 2004, 64:3823-3829.
35. Zindy F., et al. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:13462-13467.
36. Zindy F., et al. N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11579-11583.